New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 13, 2013
06:53 EDTAVEOAveo: Interim analysis of Phase 2 BATON study unlikely to meet primary endpoint
AVEO Oncology announced that data from a planned interim analysis of the Phase 2 BATON study in patients with colorectal cancer indicate that the study is unlikely to meet the primary endpoint in the intent-to-treat patient population. Data from the planned interim analysis, including biomarker data, are being analyzed, and AVEO and Astellas are in discussions regarding next steps.
News For AVEO From The Last 14 Days
Check below for free stories on AVEO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2014
06:36 EDTAVEOAveo Pharmaceuticals and Biodesix to co-develop Ficlatuzumab
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use